P. Sur

508 total citations
21 papers, 429 citations indexed

About

P. Sur is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, P. Sur has authored 21 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in P. Sur's work include Tea Polyphenols and Effects (4 papers), Folate and B Vitamins Research (4 papers) and Boron Compounds in Chemistry (3 papers). P. Sur is often cited by papers focused on Tea Polyphenols and Effects (4 papers), Folate and B Vitamins Research (4 papers) and Boron Compounds in Chemistry (3 papers). P. Sur collaborates with scholars based in India and United States. P. Sur's co-authors include J. R. Vedasiromoni, A. Gomes, Dilip Ganguly, Moitreyi Das, David G. Priest, M.T. Doig, Shila Elizabeth Besra, Amartya Sen, Kakali Sarkar and Arun K. Das and has published in prestigious journals such as Journal of Neurochemistry, Life Sciences and Cancer Letters.

In The Last Decade

P. Sur

21 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Sur India 11 168 119 69 69 65 21 429
Hideto Kimura Japan 12 203 1.2× 78 0.7× 154 2.2× 86 1.2× 54 0.8× 32 528
Jong Moon Hur South Korea 12 221 1.3× 120 1.0× 91 1.3× 66 1.0× 50 0.8× 24 491
Hee-Juhn Park South Korea 13 352 2.1× 167 1.4× 73 1.1× 58 0.8× 79 1.2× 17 632
Massimiliano Broccoli Italy 11 227 1.4× 83 0.7× 56 0.8× 37 0.5× 87 1.3× 18 519
Pritam Bhagwan Bhosale South Korea 13 280 1.7× 96 0.8× 94 1.4× 40 0.6× 61 0.9× 37 592
Jing Hao China 17 365 2.2× 191 1.6× 118 1.7× 94 1.4× 38 0.6× 41 867
Ervi Afifah Indonesia 12 71 0.4× 122 1.0× 103 1.5× 63 0.9× 47 0.7× 29 423
Laïd Selloum Algeria 9 157 0.9× 132 1.1× 103 1.5× 60 0.9× 18 0.3× 12 377
Hsüch‐Ching Chiang Taiwan 11 267 1.6× 113 0.9× 73 1.1× 63 0.9× 32 0.5× 18 507
Samuel Joshua Pragasam India 7 133 0.8× 76 0.6× 77 1.1× 71 1.0× 15 0.2× 8 422

Countries citing papers authored by P. Sur

Since Specialization
Citations

This map shows the geographic impact of P. Sur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Sur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Sur more than expected).

Fields of papers citing papers by P. Sur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Sur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Sur. The network helps show where P. Sur may publish in the future.

Co-authorship network of co-authors of P. Sur

This figure shows the co-authorship network connecting the top 25 collaborators of P. Sur. A scholar is included among the top collaborators of P. Sur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Sur. P. Sur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomes, A., Moitreyi Das, P. Sur, et al.. (2003). Glycosmis arborea extract as a hepatoprotective agent. Phytotherapy Research. 17(5). 571–574. 10 indexed citations
2.
Chattopadhyay, Partha, Shila Elizabeth Besra, A. Gomes, et al.. (2003). Anti-inflammatory activity of tea (Camellia sinensis) root extract. Life Sciences. 74(15). 1839–1849. 47 indexed citations
3.
Sur, P., Eric A. Sribnick, James Michael Wingrave, et al.. (2002). Estrogen attenuates oxidative stress‐induced apoptosis in C6 glial cells. Journal of Neurochemistry. 81(s1). 101–105. 3 indexed citations
4.
Ghosh, Paulomi, Andreia C. Gomes, Sumonto Mitra, et al.. (2002). Antineoplastic effect of new boron compounds against leukemic cell lines and cells from leukemic patients.. PubMed. 21(3). 351–6. 8 indexed citations
5.
Das, Moitreyi, Nabendu Murmu, Sumonto Mitra, et al.. (2002). Studies with black tea and its constituents on leukemic cells and cell lines.. PubMed. 21(4). 563–8. 25 indexed citations
6.
Sur, P., Moitreyi Das, A. Gomes, et al.. (2001). Trigonella foenum graecum (fenugreek) seed extract as an antineoplastic agent. Phytotherapy Research. 15(3). 257–259. 77 indexed citations
7.
Sur, P., et al.. (2001). Antiinflammatory and antioxidant property of saponins of tea [Camellia sinensis (L) O. Kuntze] root extract. Phytotherapy Research. 15(2). 174–176. 88 indexed citations
8.
Mitra, Siddhartha S., Madhusudan Das, Manosij Ghosh, et al.. (2001). Boron compounds against human leukemic cells.. PubMed. 20(4). 511–5. 5 indexed citations
9.
Das, Arun K., et al.. (2000). An antitumor pectic polysaccharide from Feronia limonia. International Journal of Biological Macromolecules. 27(5). 333–335. 57 indexed citations
10.
Sur, P., et al.. (2000). A fraction isolated from Ehrlich ascites carcinoma as an antitumor and differentiating agent against human leukemic cell ML-2.. PubMed. 47(2). 114–7. 1 indexed citations
11.
Ghosh, Prasanta, et al.. (1999). A New Boron Compound (Guanidine Biboric Acid Adduct) as an Antitumour Agent against Ehrlich Ascites Carcinoma in Mice. Tumor Biology. 20(1). 44–51. 4 indexed citations
12.
Ghosh, Prasanta, et al.. (1998). Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.. PubMed. 45(2). 68–72. 3 indexed citations
13.
Sur, P., et al.. (1998). Effect of tea root extract (TRE) on solid tumours induced by 3-methylcholanthrene in mice. Phytotherapy Research. 12(1). 62–64. 10 indexed citations
14.
Ghosh, Prabir, et al.. (1998). On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells.. PubMed. 45(6). 384–8. 2 indexed citations
15.
Sur, P., et al.. (1997). Antineoplastic activity of copper-benzohydroxamic acid complex against Ehrlich ascites carcinoma (EAC) in mice. Indian Journal of Pharmacology. 29(3). 157. 9 indexed citations
16.
Sur, P., et al.. (1997). Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.. PubMed. 44(3). 197–201. 16 indexed citations
17.
Fernandes, Daniel, P. Sur, Timothy E. Kute, & Robert L. Capizzi. (1988). Proliferation-dependent cytotoxicity of methotrexate in murine L5178Y leukemia.. PubMed. 48(20). 5638–44. 9 indexed citations
18.
Sur, P., et al.. (1986). Effects of methotrexate on folates in Krebs ascites and L1210 murine leukemia cells. Cancer Letters. 30(1). 55–59. 14 indexed citations
19.
Doig, M.T., Jamie Peters, P. Sur, Mei Dang, & David G. Priest. (1985). Determination of mouse liver 5-methyltetrahydrofolate concentration and polyglutamate forms. Journal of Biochemical and Biophysical Methods. 10(5-6). 287–294. 17 indexed citations
20.
Sur, P., M.T. Doig, & David G. Priest. (1983). Response of methylenetetrahydrofolate levels to methotrexate in Krebs ascites cells. Biochemical Journal. 216(2). 295–298. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026